A heads up. On May 23rd Celldex is holding a confernece call to release top line data on CDX-011. CDX-011 is the drug for breast cancer that uses SGEN ADC technology. They had a clerical snafu and were shut out of ASCO so they are releasing an advance of ASCO. DISC-Long SGEN no position in CLDX.
I am waiting on a dip below $4 in CLDX before picking up another 200 shares. I'm a small player, only have 400 shares currently, but am working on building my profile. Have owned 150 shares of SGEN since 2002... Dollar cost on that is $6.50